PHARMACYTE BIOTECH, INC. Debt Conversion, Original Debt, Amount
PHARMACYTE BIOTECH, INC. (PMCB) reported Debt Conversion, Original Debt, Amount of $20.00 thousand for the 12-month period ending 2014-04-30, per its 10-Q filed 2015-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2015-03-13
| Period end | Debt Conversion, Original Debt, Amount 1 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|
| 2014-04-30 | $20.00K 10-Q · filed 2015-03-13 | |
| 2013-05-31 | $471.01K 10-Q · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |